DarioHealth (DRIO) Stock Overview
Operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
DRIO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
DarioHealth Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.24 |
| 52 Week High | US$17.74 |
| 52 Week Low | US$5.94 |
| Beta | 1.16 |
| 1 Month Change | -28.66% |
| 3 Month Change | -28.60% |
| 1 Year Change | -41.59% |
| 3 Year Change | -89.95% |
| 5 Year Change | -98.01% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
DarioHealth Corp.'s (NASDAQ:DRIO) 27% Share Price Plunge Could Signal Some Risk
Feb 06
Does DarioHealth (NASDAQ:DRIO) Have A Healthy Balance Sheet?
Dec 23DarioHealth Corp. (NASDAQ:DRIO) Stock's 42% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 21Downgrade: Here's How Analysts See DarioHealth Corp. (NASDAQ:DRIO) Performing In The Near Term
Aug 15DarioHealth Corp. (NASDAQ:DRIO) Doing What It Can To Lift Shares
Aug 01DarioHealth Corp. (NASDAQ:DRIO) Screens Well But There Might Be A Catch
Apr 17
Twill Integration And GLP-1 Focus Will Expand Health Solutions
DarioHealth is positioned for significant revenue growth through strategic integrations, rising demand for companion solutions, and expanding market reach via partnerships.Slammed 25% DarioHealth Corp. (NASDAQ:DRIO) Screens Well Here But There Might Be A Catch
Nov 17A Piece Of The Puzzle Missing From DarioHealth Corp.'s (NASDAQ:DRIO) 27% Share Price Climb
Oct 03Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 30% Lower
Aug 09Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues
May 31DarioHealth Corp. (NASDAQ:DRIO) Shares Could Be 23% Below Their Intrinsic Value Estimate
Feb 16Time To Worry? Analysts Just Downgraded Their DarioHealth Corp. (NASDAQ:DRIO) Outlook
Nov 06Shareholder Returns
| DRIO | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -9.4% | 2.6% | -0.7% |
| 1Y | -41.6% | -33.4% | 16.5% |
Return vs Industry: DRIO underperformed the US Healthcare Services industry which returned -34% over the past year.
Return vs Market: DRIO underperformed the US Market which returned 16.5% over the past year.
Price Volatility
| DRIO volatility | |
|---|---|
| DRIO Average Weekly Movement | 12.2% |
| Healthcare Services Industry Average Movement | 9.7% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: DRIO's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: DRIO's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 199 | Erez Raphael | www.dariohealth.com |
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1.
DarioHealth Corp. Fundamentals Summary
| DRIO fundamental statistics | |
|---|---|
| Market cap | US$60.35m |
| Earnings (TTM) | -US$41.71m |
| Revenue (TTM) | US$22.36m |
Is DRIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DRIO income statement (TTM) | |
|---|---|
| Revenue | US$22.36m |
| Cost of Revenue | US$8.02m |
| Gross Profit | US$14.34m |
| Other Expenses | US$56.05m |
| Earnings | -US$41.71m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.17 |
| Gross Margin | 64.11% |
| Net Profit Margin | -186.56% |
| Debt/Equity Ratio | 45.3% |
How did DRIO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/19 12:02 |
| End of Day Share Price | 2026/03/19 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DarioHealth Corp. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | CG Capital |
| Theodore O'Neill | Litchfield Hills Research, LLC |
| David Grossman | Stifel, Equities Research |